Zolpimist, page-3

We can’t buy them because it’s not yet licenced in Aus. It’s not up to Suda to market the stuff.
If you read up about Aytu in the US, they are in the process of an accelerated launch into the sleep deprivation area, so fair to assume, they will be driving Zolpi hard. Aytu seems to have favourable broker recommendations etc... Aytu are due to report in the not tooo distant future which should provide an insight into the level of market penetration achieved to date following their acquisition of zolpimist.. Well see I suppose...